controls had important serological findings. 12 patients had neutralising antibody titres of -256 to coxsackieviruses B1-5 (six positive for enteroviral RNA sequences, six negative); three were positive for Epstein-Barr virus specific IgM (two positive, one negative). Six controls had similar neutralising antibody titres to coxsackieviruses (all negative); one was positive for Epstein-Barr virus specific IgM (negative); and three had titres of complement fixing antibody -256 to cytomegalovirus-(all negative). Overall, significantly more patients than controls had enteroviral RNA sequences in muscle (32/60, 53% v 6/41, 15%; odds ratio 6-7, 95% confidence interval [2] [3] [4] 
Results
The routine laboratory investigations disclosed no significant abnormalities and the samples of muscle showed no evidence of inflammation or necrosis. Only mild to moderate, non-specific atrophy of type 2 fibres was detectable in the biopsy specimens, in keeping with a chronic illness. Of the 60 patients, 12 had neutralising titres of 3256 to one of the coxsackie- . with the polymerase chain reaction and six were negative), three were positive for Epstein-Barr virus specific IgM (two positive and one negative), and there were no other significant findings. Of the 41 controls, six had neutralising titres of 3256 to one of the coxsackieviruses B1-5 (all negative with the polymerase chain reaction), one was positive for EpsteinBarr virus specific IgM (negative), and three had complement fixing antibody to cytomegalovirus titres of ¢256 (all negative). In summary, 25% of the patients and 24-4% of the controls had significant serological findings.
To assess the feasibility of applying the polymerase chain reaction technique to detecting enteroviral RNA in muscle it was first necessary to show that a sequence common to various enteroviral types could be amplified. Figure 1 shows that the enteroviral polymerase chain reaction primers EP1 and EP4 amplified a specific 414 base pair band from cells infected with coxsackieviruses A and B (lanes 1-8) but not from the uninfected cell lines or normal human muscle (lanes 9-12). The presence of enteroviral sequences in the polymerase chain reaction bands was confirmed by Southern blot analysis and hybridisation with the internal oligonucleotide probe EP2 (fig 1) .
The primers EPI and EP4 also amplified a common sequence from poliovirus, echovirus, and higher enterovirus types (fig 2) . Figure 2 confirms the viral sequence. Echovirus 22 (fig 2a, lane 6 staining (fig lb) . Enterovirus 68, which gave rise to a band slightly larger than 414 base pairs (fig 2a) did not hybridise with probe EP2.
Though there is sequence variation within the enteroviral group at the 5' end, there is sufficient conservation to regard the primers selected as being of broad specificity for a wide range of enterovirus. Amplification of the uninfected cell controls, normal human muscle, and measles virus (not shown) was consistently negative, showing the specificity of the enteroviral primers.
To assess the sensitivity of the polymerase chain reaction technique 5 jig total RNA from coxsackievirus B3 infected HEp 2 cells was serially diluted with RNA from uninfected cells. The cells had been washed several times with phosphate buffered saline during harvest to remove any free virus particles from the culture medium. Dilutions from 1 in 10 to 1 in 107 were made. A positive band was visible by ethidium bromide staining at the 1 in 104 dilution, and after hybridisation with an internal probe a positive signal was visible in autoradiographs for dilutions down to 1 in 106 (not shown). RNA at a dilution of 1 in 103 from coxsackievirus B3 infected/uninfected cells was routinely used as the positive control in each experiment. Figure 3 shows examples of ABL gene and enteroviral polymerase chain reaction products from muscle biopsy specimens from three patients with the postviral fatigue syndrome. The 218 base pair ABL gene band was observed in all samples by gel electrophoresis and ethidium bromide staining. A visible 414 base pair enteroviral band from 20 jtl polymerase chain reaction product was present in 16% of biopsy specimens from patients with postviral fatigue syndrome. To increase the sensitivity 60 jil of polymerase chain reaction product was slot-blotted on to nylon and hybridised with 32P-labelled probe EP2. Figure 4 shows an example ofa typical slot-blot experiment. Most positive samples could be readily detected in the autoradiographs after a 16 hour exposure. Autoradiographs were re-exposed for 10 days to ensure that no weak positive signals were missed. It is important to note the difference in signal between the 1 in 103 dilution of the infected/uninfected cell control (slot G4) and the positive signals in the samples of patients' muscle, suggesting that either the number of viral copies per cell is very low or very few cells were infected.
Of the 60 patients with the postviral fatigue syndrome, 32 (53%) were positive for enteroviral RNA sequences in muscle after polymerase chain reaction amplification and hybridisation with EP2, and of the 41 controls, six (15%) were positive. Statistical analysis with the x2 test shows that these results are highly significant (p<0{001, (ct=005, df= 1, x2 with correction for continuity= 13-94; therefore p<0O001)). The relative odds ratio of the postviral fatigue syndrome in patients with enteroviral infection was 6-7 (32x35/28x6) (95% confidence interval 2-4 to 18-2). Enteroviral sequences were detected in 12 of the 27 male and 20 of the 33 female patients. There was no correlation between duration of disease, patient, and age and positivity by polymerase chain reaction. 
Discussion
In this study we investigated a large group of patients with the postviral fatigue syndrome for the presence of persistent enterovirus infection in muscle. The criteria we used are similar to those proposed as a working case definition of the chronic fatigue syndrome,7 but we purposely avoided this term because it is so non-specific and depends largely on the exclusion of a vast number of different syndromes.
The control sample was taken from the same catchment area and was studied over the same period as the patients. It is very likely that the groups had the same exposure to common viruses as serological tests disclosed similar results in the two: 25% ofpatients and 24 1% of controls had increased antibody titres to coxsackieviruses, Epstein-Barr virus, or cytomegalovirus. None ofthe controls had any muscular problems.
It was not considered ethical or practicable to perform biopsy in a large group of normal healthy subjects, so that the control sample consisted of patients undergoing surgical procedures, from whom a minute fragment of muscle could be obtained at operation. This accounts for the slightly different age and sex structure of this group.
The epidemiology of the postviral fatigue syndrome, its incubation period, and the abrupt onset ofa feverish illness all suggest that a viral infection is responsible. However, no virus has been found to be consistently associated. Serological analysis for viral antigens has been unhelpful,3 as we confirmed in a recent study. '6 In this study there was no correlation between raised titres to coxsackieviruses B1-5 and the detection of enterovirus specific RNA in muscle biopsy specimens.
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In view of the broad specificity of the polymerase chain reaction technique used for a wide range of enteroviruses, this is not surprising. In both patient and control groups three quarters of the subjects had no significant serological findings. These results are in keeping with those in our larger, serological study. 16 Several groups have presented data on polymerase chain reaction of enterovirus.' ' We used this technique to search for enteroviral RNA in muscle because its exquisite sensitivity enables the detection of a few copies of enteroviral sequences in the cell. Previously, with nucleic acid hybridisation, a fifth of pati*nts with the postviral fatigue syndrome were positive for enterovirus specific sequences." We found that 53% of 60 patients with the syndrome had specific enteroviral RNA, suggesting persistent infection in the muscle. These results are statistically significant; the relative odds ratio for the postviral fatigue syndrome in patients with enteroviral infection is [6] [7] We emphasise that at present we do not regard the polymerase chain reaction for enteroviral sequences as a "diagnostic test" for the postviral fatigue syndrome. At this stage it is a research tool, which in due course may lead to a diagnostic test becoming available. In this study no healthy young adult had a positive result with the polymerase chain reaction for enterovirus. Among our 41 control patients undergoing surgical procedures, six had a positive result, all of whom had a malignant tumour (five carcinoma of the breast and one carcinoma of the colon). The significance of this finding is at Dresent unknown.
A major difficulty in postulating a viral cause for the postviral fatigue syndrome has been the lack of any morphological evidence of cell injury or inflammation. None of our patients had increased serum creatine kinase activity or cell necrosis on muscle biopsy. Oldstone showed clearly in animal models, however, that viruses may infect tissue persistently without producing any morphological effect, although they do interfere, partially or completely, with the specialised function of the host cell.'9 Viral persistence seems to be particularly likely if the agent infects longlived cells such as lymphocytes or cells in the nervous system. Enteroviruses are known to produce continuing infection in humans,2°and recent work on a very small sample of patients with the postviral fatigue syndrome suggested that there is an unusual ratio of sense to antisense copies of the viral RNA, perhaps accounting for its persistence.2'
The features of the postviral fatigue syndrome point to involvement of the nervous system as well as muscle. It is tempting to speculate that virus remains here also, perhaps interfering with cellular production of neurotransmitters; it may also be associated with the depression.
On the basis of the results of this study we postulate that there is persistent enteroviral infection in the muscle of some patients with the postviral fatigue syndrome and that this interferes with cell metabolism and is causally relgted to the fatigue.
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